Global Neuroleptics Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Neuroleptics Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Neuroleptics by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Neuroleptics by Country/Region, 2017, 2022 & 2028

2.2 Neuroleptics Segment by Type

2.2.1 First Generation

2.2.2 Second Generation

2.2.3 Third Generation

2.3 Neuroleptics Sales by Type

2.3.1 Global Neuroleptics Sales Market Share by Type (2017-2022)

2.3.2 Global Neuroleptics Revenue and Market Share by Type (2017-2022)

2.3.3 Global Neuroleptics Sale Price by Type (2017-2022)

2.4 Neuroleptics Segment by Application

2.4.1 Schizophrenia

2.4.2 Bipolar Disorder

2.4.3 Unipolar Depression

2.4.4 Dementia

2.4.5 Others

2.5 Neuroleptics Sales by Application

2.5.1 Global Neuroleptics Sale Market Share by Application (2017-2022)

2.5.2 Global Neuroleptics Revenue and Market Share by Application (2017-2022)

2.5.3 Global Neuroleptics Sale Price by Application (2017-2022)

3 Global Neuroleptics by Company

3.1 Global Neuroleptics Breakdown Data by Company

3.1.1 Global Neuroleptics Annual Sales by Company (2020-2022)

3.1.2 Global Neuroleptics Sales Market Share by Company (2020-2022)

3.2 Global Neuroleptics Annual Revenue by Company (2020-2022)

3.2.1 Global Neuroleptics Revenue by Company (2020-2022)

3.2.2 Global Neuroleptics Revenue Market Share by Company (2020-2022)

3.3 Global Neuroleptics Sale Price by Company

3.4 Key Manufacturers Neuroleptics Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Neuroleptics Product Location Distribution

3.4.2 Players Neuroleptics Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Neuroleptics by Geographic Region

4.1 World Historic Neuroleptics Market Size by Geographic Region (2017-2022)

4.1.1 Global Neuroleptics Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Neuroleptics Annual Revenue by Geographic Region

4.2 World Historic Neuroleptics Market Size by Country/Region (2017-2022)

4.2.1 Global Neuroleptics Annual Sales by Country/Region (2017-2022)

4.2.2 Global Neuroleptics Annual Revenue by Country/Region

4.3 Americas Neuroleptics Sales Growth

4.4 APAC Neuroleptics Sales Growth

4.5 Europe Neuroleptics Sales Growth

4.6 Middle East & Africa Neuroleptics Sales Growth

5 Americas

5.1 Americas Neuroleptics Sales by Country

5.1.1 Americas Neuroleptics Sales by Country (2017-2022)

5.1.2 Americas Neuroleptics Revenue by Country (2017-2022)

5.2 Americas Neuroleptics Sales by Type

5.3 Americas Neuroleptics Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Neuroleptics Sales by Region

6.1.1 APAC Neuroleptics Sales by Region (2017-2022)

6.1.2 APAC Neuroleptics Revenue by Region (2017-2022)

6.2 APAC Neuroleptics Sales by Type

6.3 APAC Neuroleptics Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Neuroleptics by Country

7.1.1 Europe Neuroleptics Sales by Country (2017-2022)

7.1.2 Europe Neuroleptics Revenue by Country (2017-2022)

7.2 Europe Neuroleptics Sales by Type

7.3 Europe Neuroleptics Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Neuroleptics by Country

8.1.1 Middle East & Africa Neuroleptics Sales by Country (2017-2022)

8.1.2 Middle East & Africa Neuroleptics Revenue by Country (2017-2022)

8.2 Middle East & Africa Neuroleptics Sales by Type

8.3 Middle East & Africa Neuroleptics Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Neuroleptics

10.3 Manufacturing Process Analysis of Neuroleptics

10.4 Industry Chain Structure of Neuroleptics

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Neuroleptics Distributors

11.3 Neuroleptics Customer

12 World Forecast Review for Neuroleptics by Geographic Region

12.1 Global Neuroleptics Market Size Forecast by Region

12.1.1 Global Neuroleptics Forecast by Region (2023-2028)

12.1.2 Global Neuroleptics Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Neuroleptics Forecast by Type

12.7 Global Neuroleptics Forecast by Application

13 Key Players Analysis

13.1 Johnson & Johnson

13.1.1 Johnson & Johnson Company Information

13.1.2 Johnson & Johnson Neuroleptics Product Offered

13.1.3 Johnson & Johnson Neuroleptics Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Johnson & Johnson Main Business Overview

13.1.5 Johnson & Johnson Latest Developments

13.2 Pfizer

13.2.1 Pfizer Company Information

13.2.2 Pfizer Neuroleptics Product Offered

13.2.3 Pfizer Neuroleptics Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Pfizer Main Business Overview

13.2.5 Pfizer Latest Developments

13.3 Eli Lilly

13.3.1 Eli Lilly Company Information

13.3.2 Eli Lilly Neuroleptics Product Offered

13.3.3 Eli Lilly Neuroleptics Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Eli Lilly Main Business Overview

13.3.5 Eli Lilly Latest Developments

13.4 Bristol-Myers Squibb

13.4.1 Bristol-Myers Squibb Company Information

13.4.2 Bristol-Myers Squibb Neuroleptics Product Offered

13.4.3 Bristol-Myers Squibb Neuroleptics Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Bristol-Myers Squibb Main Business Overview

13.4.5 Bristol-Myers Squibb Latest Developments

13.5 AstraZeneca

13.5.1 AstraZeneca Company Information

13.5.2 AstraZeneca Neuroleptics Product Offered

13.5.3 AstraZeneca Neuroleptics Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 AstraZeneca Main Business Overview

13.5.5 AstraZeneca Latest Developments

13.6 GSK

13.6.1 GSK Company Information

13.6.2 GSK Neuroleptics Product Offered

13.6.3 GSK Neuroleptics Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 GSK Main Business Overview

13.6.5 GSK Latest Developments

13.7 Allergan

13.7.1 Allergan Company Information

13.7.2 Allergan Neuroleptics Product Offered

13.7.3 Allergan Neuroleptics Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Allergan Main Business Overview

13.7.5 Allergan Latest Developments

14 Research Findings and Conclusion

Table 1. Neuroleptics Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Neuroleptics Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of First Generation

Table 4. Major Players of Second Generation

Table 5. Major Players of Third Generation

Table 6. Global Neuroleptics Sales by Type (2017-2022) & (K MT)

Table 7. Global Neuroleptics Sales Market Share by Type (2017-2022)

Table 8. Global Neuroleptics Revenue by Type (2017-2022) & ($ million)

Table 9. Global Neuroleptics Revenue Market Share by Type (2017-2022)

Table 10. Global Neuroleptics Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global Neuroleptics Sales by Application (2017-2022) & (K MT)

Table 12. Global Neuroleptics Sales Market Share by Application (2017-2022)

Table 13. Global Neuroleptics Revenue by Application (2017-2022)

Table 14. Global Neuroleptics Revenue Market Share by Application (2017-2022)

Table 15. Global Neuroleptics Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global Neuroleptics Sales by Company (2020-2022) & (K MT)

Table 17. Global Neuroleptics Sales Market Share by Company (2020-2022)

Table 18. Global Neuroleptics Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Neuroleptics Revenue Market Share by Company (2020-2022)

Table 20. Global Neuroleptics Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers Neuroleptics Producing Area Distribution and Sales Area

Table 22. Players Neuroleptics Products Offered

Table 23. Neuroleptics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Neuroleptics Sales by Geographic Region (2017-2022) & (K MT)

Table 27. Global Neuroleptics Sales Market Share Geographic Region (2017-2022)

Table 28. Global Neuroleptics Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Neuroleptics Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Neuroleptics Sales by Country/Region (2017-2022) & (K MT)

Table 31. Global Neuroleptics Sales Market Share by Country/Region (2017-2022)

Table 32. Global Neuroleptics Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Neuroleptics Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Neuroleptics Sales by Country (2017-2022) & (K MT)

Table 35. Americas Neuroleptics Sales Market Share by Country (2017-2022)

Table 36. Americas Neuroleptics Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Neuroleptics Revenue Market Share by Country (2017-2022)

Table 38. Americas Neuroleptics Sales by Type (2017-2022) & (K MT)

Table 39. Americas Neuroleptics Sales Market Share by Type (2017-2022)

Table 40. Americas Neuroleptics Sales by Application (2017-2022) & (K MT)

Table 41. Americas Neuroleptics Sales Market Share by Application (2017-2022)

Table 42. APAC Neuroleptics Sales by Region (2017-2022) & (K MT)

Table 43. APAC Neuroleptics Sales Market Share by Region (2017-2022)

Table 44. APAC Neuroleptics Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Neuroleptics Revenue Market Share by Region (2017-2022)

Table 46. APAC Neuroleptics Sales by Type (2017-2022) & (K MT)

Table 47. APAC Neuroleptics Sales Market Share by Type (2017-2022)

Table 48. APAC Neuroleptics Sales by Application (2017-2022) & (K MT)

Table 49. APAC Neuroleptics Sales Market Share by Application (2017-2022)

Table 50. Europe Neuroleptics Sales by Country (2017-2022) & (K MT)

Table 51. Europe Neuroleptics Sales Market Share by Country (2017-2022)

Table 52. Europe Neuroleptics Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Neuroleptics Revenue Market Share by Country (2017-2022)

Table 54. Europe Neuroleptics Sales by Type (2017-2022) & (K MT)

Table 55. Europe Neuroleptics Sales Market Share by Type (2017-2022)

Table 56. Europe Neuroleptics Sales by Application (2017-2022) & (K MT)

Table 57. Europe Neuroleptics Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Neuroleptics Sales by Country (2017-2022) & (K MT)

Table 59. Middle East & Africa Neuroleptics Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Neuroleptics Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Neuroleptics Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Neuroleptics Sales by Type (2017-2022) & (K MT)

Table 63. Middle East & Africa Neuroleptics Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Neuroleptics Sales by Application (2017-2022) & (K MT)

Table 65. Middle East & Africa Neuroleptics Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Neuroleptics

Table 67. Key Market Challenges & Risks of Neuroleptics

Table 68. Key Industry Trends of Neuroleptics

Table 69. Neuroleptics Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Neuroleptics Distributors List

Table 72. Neuroleptics Customer List

Table 73. Global Neuroleptics Sales Forecast by Region (2023-2028) & (K MT)

Table 74. Global Neuroleptics Sales Market Forecast by Region

Table 75. Global Neuroleptics Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Neuroleptics Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Neuroleptics Sales Forecast by Country (2023-2028) & (K MT)

Table 78. Americas Neuroleptics Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Neuroleptics Sales Forecast by Region (2023-2028) & (K MT)

Table 80. APAC Neuroleptics Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Neuroleptics Sales Forecast by Country (2023-2028) & (K MT)

Table 82. Europe Neuroleptics Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Neuroleptics Sales Forecast by Country (2023-2028) & (K MT)

Table 84. Middle East & Africa Neuroleptics Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Neuroleptics Sales Forecast by Type (2023-2028) & (K MT)

Table 86. Global Neuroleptics Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Neuroleptics Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Neuroleptics Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Neuroleptics Sales Forecast by Application (2023-2028) & (K MT)

Table 90. Global Neuroleptics Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Neuroleptics Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Neuroleptics Revenue Market Share Forecast by Application (2023-2028)

Table 93. Johnson & Johnson Basic Information, Neuroleptics Manufacturing Base, Sales Area and Its Competitors

Table 94. Johnson & Johnson Neuroleptics Product Offered

Table 95. Johnson & Johnson Neuroleptics Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. Johnson & Johnson Main Business

Table 97. Johnson & Johnson Latest Developments

Table 98. Pfizer Basic Information, Neuroleptics Manufacturing Base, Sales Area and Its Competitors

Table 99. Pfizer Neuroleptics Product Offered

Table 100. Pfizer Neuroleptics Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. Pfizer Main Business

Table 102. Pfizer Latest Developments

Table 103. Eli Lilly Basic Information, Neuroleptics Manufacturing Base, Sales Area and Its Competitors

Table 104. Eli Lilly Neuroleptics Product Offered

Table 105. Eli Lilly Neuroleptics Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. Eli Lilly Main Business

Table 107. Eli Lilly Latest Developments

Table 108. Bristol-Myers Squibb Basic Information, Neuroleptics Manufacturing Base, Sales Area and Its Competitors

Table 109. Bristol-Myers Squibb Neuroleptics Product Offered

Table 110. Bristol-Myers Squibb Neuroleptics Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. Bristol-Myers Squibb Main Business

Table 112. Bristol-Myers Squibb Latest Developments

Table 113. AstraZeneca Basic Information, Neuroleptics Manufacturing Base, Sales Area and Its Competitors

Table 114. AstraZeneca Neuroleptics Product Offered

Table 115. AstraZeneca Neuroleptics Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. AstraZeneca Main Business

Table 117. AstraZeneca Latest Developments

Table 118. GSK Basic Information, Neuroleptics Manufacturing Base, Sales Area and Its Competitors

Table 119. GSK Neuroleptics Product Offered

Table 120. GSK Neuroleptics Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 121. GSK Main Business

Table 122. GSK Latest Developments

Table 123. Allergan Basic Information, Neuroleptics Manufacturing Base, Sales Area and Its Competitors

Table 124. Allergan Neuroleptics Product Offered

Table 125. Allergan Neuroleptics Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 126. Allergan Main Business

Table 127. Allergan Latest Developments

List of Figures

Figure 1. Picture of Neuroleptics

Figure 2. Neuroleptics Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Neuroleptics Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Neuroleptics Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Neuroleptics Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of First Generation

Figure 10. Product Picture of Second Generation

Figure 11. Product Picture of Third Generation

Figure 12. Global Neuroleptics Sales Market Share by Type in 2021

Figure 13. Global Neuroleptics Revenue Market Share by Type (2017-2022)

Figure 14. Neuroleptics Consumed in Schizophrenia

Figure 15. Global Neuroleptics Market: Schizophrenia (2017-2022) & (K MT)

Figure 16. Neuroleptics Consumed in Bipolar Disorder

Figure 17. Global Neuroleptics Market: Bipolar Disorder (2017-2022) & (K MT)

Figure 18. Neuroleptics Consumed in Unipolar Depression

Figure 19. Global Neuroleptics Market: Unipolar Depression (2017-2022) & (K MT)

Figure 20. Neuroleptics Consumed in Dementia

Figure 21. Global Neuroleptics Market: Dementia (2017-2022) & (K MT)

Figure 22. Neuroleptics Consumed in Others

Figure 23. Global Neuroleptics Market: Others (2017-2022) & (K MT)

Figure 24. Global Neuroleptics Sales Market Share by Application (2017-2022)

Figure 25. Global Neuroleptics Revenue Market Share by Application in 2021

Figure 26. Neuroleptics Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Neuroleptics Revenue Market Share by Company in 2021

Figure 28. Global Neuroleptics Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Neuroleptics Revenue Market Share by Geographic Region in 2021

Figure 30. Global Neuroleptics Sales Market Share by Region (2017-2022)

Figure 31. Global Neuroleptics Revenue Market Share by Country/Region in 2021

Figure 32. Americas Neuroleptics Sales 2017-2022 (K MT)

Figure 33. Americas Neuroleptics Revenue 2017-2022 ($ Millions)

Figure 34. APAC Neuroleptics Sales 2017-2022 (K MT)

Figure 35. APAC Neuroleptics Revenue 2017-2022 ($ Millions)

Figure 36. Europe Neuroleptics Sales 2017-2022 (K MT)

Figure 37. Europe Neuroleptics Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Neuroleptics Sales 2017-2022 (K MT)

Figure 39. Middle East & Africa Neuroleptics Revenue 2017-2022 ($ Millions)

Figure 40. Americas Neuroleptics Sales Market Share by Country in 2021

Figure 41. Americas Neuroleptics Revenue Market Share by Country in 2021

Figure 42. United States Neuroleptics Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Neuroleptics Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Neuroleptics Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Neuroleptics Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Neuroleptics Sales Market Share by Region in 2021

Figure 47. APAC Neuroleptics Revenue Market Share by Regions in 2021

Figure 48. China Neuroleptics Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Neuroleptics Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Neuroleptics Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Neuroleptics Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Neuroleptics Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Neuroleptics Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Neuroleptics Sales Market Share by Country in 2021

Figure 55. Europe Neuroleptics Revenue Market Share by Country in 2021

Figure 56. Germany Neuroleptics Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Neuroleptics Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Neuroleptics Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Neuroleptics Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Neuroleptics Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Neuroleptics Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Neuroleptics Revenue Market Share by Country in 2021

Figure 63. Egypt Neuroleptics Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Neuroleptics Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Neuroleptics Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Neuroleptics Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Neuroleptics Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Neuroleptics in 2021

Figure 69. Manufacturing Process Analysis of Neuroleptics

Figure 70. Industry Chain Structure of Neuroleptics

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles